| Product Code: ETC7755541 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Cardiac Biomarkers Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Cardiac Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Cardiac Biomarkers Market - Industry Life Cycle |
3.4 Jordan Cardiac Biomarkers Market - Porter's Five Forces |
3.5 Jordan Cardiac Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Jordan Cardiac Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Jordan Cardiac Biomarkers Market Revenues & Volume Share, By Location of Testing, 2021 & 2031F |
4 Jordan Cardiac Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Jordan |
4.2.2 Growing adoption of advanced diagnostic technologies |
4.2.3 Rising awareness about early detection and prevention of cardiac conditions |
4.3 Market Restraints |
4.3.1 High costs associated with cardiac biomarker tests |
4.3.2 Limited reimbursement policies for cardiac biomarker testing |
4.3.3 Lack of skilled healthcare professionals for accurate interpretation of biomarker results |
5 Jordan Cardiac Biomarkers Market Trends |
6 Jordan Cardiac Biomarkers Market, By Types |
6.1 Jordan Cardiac Biomarkers Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Cardiac Biomarkers Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Jordan Cardiac Biomarkers Market Revenues & Volume, By Myocardial muscle Creatine Kinase (CK-MB), 2021- 2031F |
6.1.4 Jordan Cardiac Biomarkers Market Revenues & Volume, By Troponins (T and I), 2021- 2031F |
6.1.5 Jordan Cardiac Biomarkers Market Revenues & Volume, By Myoglobin, 2021- 2031F |
6.1.6 Jordan Cardiac Biomarkers Market Revenues & Volume, By Brain Natriuretic Peptide (BNPs) or NT-proBNP, 2021- 2031F |
6.1.7 Jordan Cardiac Biomarkers Market Revenues & Volume, By Ischemia Modified Albumin (IMA), 2021- 2031F |
6.1.8 Jordan Cardiac Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Cardiac Biomarkers Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Jordan Cardiac Biomarkers Market Revenues & Volume, By Myocardial Infarction, 2021- 2031F |
6.2.3 Jordan Cardiac Biomarkers Market Revenues & Volume, By Congestive Heart Failure, 2021- 2031F |
6.2.4 Jordan Cardiac Biomarkers Market Revenues & Volume, By Acute Coronary Syndrome, 2021- 2031F |
6.2.5 Jordan Cardiac Biomarkers Market Revenues & Volume, By Atherosclerosis, 2021- 2031F |
6.2.6 Jordan Cardiac Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Cardiac Biomarkers Market, By Location of Testing |
6.3.1 Overview and Analysis |
6.3.2 Jordan Cardiac Biomarkers Market Revenues & Volume, By Point of care testing, 2021- 2031F |
6.3.3 Jordan Cardiac Biomarkers Market Revenues & Volume, By Laboratory testing, 2021- 2031F |
7 Jordan Cardiac Biomarkers Market Import-Export Trade Statistics |
7.1 Jordan Cardiac Biomarkers Market Export to Major Countries |
7.2 Jordan Cardiac Biomarkers Market Imports from Major Countries |
8 Jordan Cardiac Biomarkers Market Key Performance Indicators |
8.1 Number of hospitals/clinics offering cardiac biomarker testing services |
8.2 Adoption rate of new cardiac biomarker technologies in Jordan |
8.3 Percentage of population undergoing regular cardiac biomarker screenings |
8.4 Research and development investments in cardiac biomarker innovations |
8.5 Rate of integration of cardiac biomarker testing in routine medical practice |
9 Jordan Cardiac Biomarkers Market - Opportunity Assessment |
9.1 Jordan Cardiac Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Jordan Cardiac Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Jordan Cardiac Biomarkers Market Opportunity Assessment, By Location of Testing, 2021 & 2031F |
10 Jordan Cardiac Biomarkers Market - Competitive Landscape |
10.1 Jordan Cardiac Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Jordan Cardiac Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here